Having been established in the UK for over 15 years, we have a deep understanding of the UK healthcare system and how to navigate the complexities involved in achieving commercial success.
Our team’s expertise in the sales and marketing of products, alongside our track record of achieving marketing authorisation, understanding pricing and reimbursement, and beyond is why we have been able to establish ourselves as renowned leaders in repurposing medicines in the UK.
Guiding your medicine's
Bringing value-added medicines to UK prescribers involves pivotal steps from regulatory approval, to developing pricing strategies, local formulary engagement, and more.
No matter your position in the product lifecycle, whether you are seeking regulatory approval, possess a dossier, or hold a marketing authorisation, we will work with you to streamline the steps to commercialisation.
We have a strong understanding of what it takes for a product to receive approval from the Medicines and Healthcare Products Regulatory Agency (MHRA) and have successfully achieved marketing authorisation for multiple products.
Our expertise lies in navigating the complexity of various UK reimbursement mechanisms. Leveraging our in-depth understanding of the UK drug tariff system, we’re able to develop appropriate pricing strategies across different reimbursement channels, which in turn enables us to drive more value for our partners.
Market Access and Commercialisation
What sets Colonis apart is our expertise to successfully navigate and commercialise a product beyond regulatory approvals.
Each in-licensed product requires a tailored market access strategy that involves adaptable commercial expertise.
Our expert analysis of the current marketplace enables us to maximise commercial opportunities to ensure value-added medicines are available to healthcare professionals and reach patients. This involves securing patient pathways, formulary listings, and guideline inclusions, orchestrating marketing and sales efforts, efficient supply chain management, and engaging with healthcare providers, professionals, and patient advocacy groups.